Skip to Main Content

Belimed

  • sam patrick posted an article
    South Carolina delegation a hit at Swiss BIO Day see more

    SCBIO and the State of South Carolina were center stage during Swiss Biotech days in Basel, Switzerland, a conference that hosted 1,000 attendees this week. 

    South Carolina demonstrated its willingness to be on the leading edge and open to partnerships and unique collaborations.  The list of dignitaries that visited with Team SC was impressive, headlined by the President of Switzerland, Ignazio Cassis.  It also included Eva Weigold Schultz, former Charge d’Affaires at the U.S. Embassy in Bern, and global life sciences leaders like AMGEN’s Henrik Asmussen, Dr. Suzanne Grund, of Geistlich Pharma, and many more. 

    I had the opportunity to talk with President Cassis and reinforce our state’s commitment to international investment and collaboration in the life sciences sector, which benefits both countries and, ultimately, translates into better patient outcomes.  As a former physician with a master’s degree in public health, he has a unique perspective on this industry.

    A roundtable discussion with Swiss Biotech Association President Michael Altorfer and other leaders highlighted our current biotech firms with a presence in both South Carolina and Switzerland. Belimed Life Science CFO Simon Engeli and CeQur CFO/EVP Douglas Gunthardt spoke about the positive business climate in the Palmetto State and the tremendous support provided as their companies expanded to the US. 

    With over 30 meetings in two days, and as a featured guest of the conference, our team of SCBIO’s Carla Whitlock, Central SC Alliance’s David King, Charleston County’s Jennifer Brown (also representing CRDA), Sebastian Nowack of the South Carolina Department of Commerce European Office in Munich, Susanna Auf de Maur (a South Carolina native and partner at Kaufmann Ruedi) and with support of the Upstate SC Alliance, successfully laid the groundwork for future investments.  We found an attentive audience as we shared the story of our impressive growth, burgeoning innovation ecosystem, and new infrastructure that is being created to support our industry. 

    We look forward to our return trip next year and to continued collaboration with the Swiss Biotech Association as we learn from each other and support the companies making a difference with innovative technologies and patient outcomes.

    Danke Schweiz...

    Erin Ford
    SCBIO COO

  • sam patrick posted an article
    More than $750,000 investment will create 22 new jobs see more

    COLUMBIA, S.C. Belimed Life Science, Inc., a leading supplier of steam sterilizers and parts washers, today announced plans to establish operations in Charleston County. The more than $750,000 investment will create 22 new jobs.

    Founded in 2019 in Switzerland, Belimed Life Science, Inc. provides Current Good Manufacturing Practices (cGMP) sterilizers and washers for the pharmaceutical and biotech markets. Specializing in machine process solutions for cleaning and sterilization, the company supplies customers on a global scale.

    Located at 2154 N. Center Street in North Charleston, Belimed Life Science, Inc.’s new facility will provide product sales and support to the company’s North American customer base.

    Hiring is underway, and individuals interested in joining the Belimed Life Science, Inc. team should visit the company’s careers website.

     

    QUOTES

    “As a manufacturer of products used in the manufacturing process of life-saving vaccines and drug therapies, Belimed Life Science is excited to open our first U.S. site in Charleston, South Carolina. As the pharmaceutical and biotech industries continue to innovate for the benefit of all of us, the need for our products and services will continue to increase requiring future growth of Belimed Life Science. What better place to begin than here in Charleston.” -Belimed Life Science, Inc. President Ken Blankenship 

    “Today's announcement by Belimed Life Science, Inc. is another win for our state's booming life sciences industry and is further testament that South Carolina is an ideal place for life science companies to locate. We celebrate the life-saving work of Belimed Life Science, Inc., and we look forward to their success in South Carolina. -Gov. Henry McMaster

    “South Carolina's growing roster of life sciences companies proves that the state has the business environment in place to meet this industry's specific needs. And, with South Carolina's commitment to supporting research, training skilled workers and advancing supplier infrastructure, we’re an ideal location for companies like Belimed Life Science, Inc. to grow and thrive.” -Secretary of Commerce Harry M. Lightsey III

    “When an international company like Belimed Life Science, Inc. invests in Charleston County, it is a testament to our people and community. We have the proven workforce and business-friendly climate that is attractive to life science companies.” -Charleston County Council Chairman Teddie Pryor

     

    FIVE FAST FACTS

    • Belimed Life Science, Inc. is establishing operations in Charleston County.
    • The more than $750,000 investment will create 22 new jobs.
    • Belimed Life Science, Inc. is a leading supplier of steam sterilizers and parts washers.
    • Located at 2154 N. Center Street in North Charleston, S.C.
    • Individuals interested in joining the Belimed Life Science, Inc. team should visit the company’s careers website.

  • sam patrick posted an article
    Belimed collaborating with 3M manufacturing see more

    Courtesy of Lowcountry Biz SC

    Can N95 respirators be decontaminated in a steam sterilization cycle for reuse in situations of severe personal protective equipment (PPE) shortage? That question has been explored through collaboration between a world-leading respirator manufacturer, 3M, and a global leader in sterilization solutions, Belimed.

    “The expert team at 3M was open-minded and very supportive in evaluating this question,” says Markus Auly, Head of Scientific Affairs at Belimed. “After two rounds of testing six different respirator models steam-treated by Belimed, and a thorough technical analysis of the data, 3M felt confident in the compatibility of the process with certain respirator models.”

    3M’s latest version of the Technical Bulletin confirms that one standard 250° F sterilization cycle in Belimed Medical Steam Sterilizer models MST-H or MST-V does not compromise the form, fit, and function of their flat-fold respirators.

    The benefit of evaluating and confirming compatibility with this standard steam sterilization process is that it is the gold standard among decontamination technologies because of its high microbiocidal efficacy, even in the presence of residual soils. From a resource standpoint, it is safe to use due to freedom from toxic residues, easy to administer, and has low processing costs, using only water and electricity.

    Steam decontamination of N95 respirators will double the availability of 3M flat-fold respirators during a supply crisis in any healthcare center that has a Belimed Steam Sterilizer MST-H or MST-V.

    During the global shortage in the last months, the supply of N95 respirators in all regions of the world, including healthcare leaders like the USA, Germany, or the Netherlands, has been tight. It soon became clear that disposing of single-use respirators after one use (standard protocol) could leave health care workers exposed due to lack of supply.

    Hospitals around the world are seeking options to provide respirators to their employees to help reduce their risk of exposure when working with confirmed or suspected COVID-19 patients. The solutions include extended use and/or contingency reprocessing methods, both of which have their challenges.

    Previously, Belimed had published a white paper explaining these reprocessing options that various countries were adopting to alleviate the scarcity of disposable personal protective equipment (PPE) like N95 respirators, surgical gowns, or face shields. The goal was to share this information with healthcare facilities across the globe. The whitepaper can be downloaded on the Belimed website.

    Now, with the evaluation by 3M of steam decontamination of N95 respirators, specific programmed cycles of the Belimed Steam Sterilizer MST-H or MST-V were determined to be compatible with specific 3M respirator models.

    “Belimed’s number one priority has always been to protect the health and safety of hospital staff and their patients. With our expertise in sterile processing we want to contribute our part and create certainty in uncertain times,” says Dominik Arnold, CEO of Belimed. “Now our customers and the healthcare community can be confident to have a more reliable fall-back solution in times of short supply of N95 respirators.”

    For more information please check 3M’s technical bulletin “Decontamination of 3M Filtering Facepiece Respirators, such as N95 Respirators, in the United States – Considerations” and Belimed’s website (www.belimed.com).

     

    About Belimed

    Belimed AG is a leading provider of product and service solutions for the sterilization, disinfection, and cleaning of medical and surgical instruments. The company, with its headquarters in Zug (Switzerland), can look back on more than 50 years of history. We are continuously developing our technology-based portfolio and are always looking for innovative solutions to improve reliability, efficiency and sustainability in sterile supply departments.

    We are engineers of confidence: we listen to our customers and find the right solutions for their challenges. We create optimal conditions for a better working environment. Our comprehensive range of sterile workflow solutions ranges from planning and conception to industry-leading systems and consumables to professional services and data connection options. In addition, we offer our customers training and further education opportunities.

    The focus of our work is the unlimited trust of our customers. Together we make an important contribution to medical progress and ensure the safety and health of patients and medical personnel.